Clinical experience with gene therapy for the treatment of prostate cancer.
Localized prostate cancer can be treated effectively with radical prostatectomy or radiation therapy. The treatment options for metastatic prostate cancer are limited to hormonal therapy; hormone-refractory cancer is treated with taxane-based chemotherapy, which provides only a modest survival benefit. New treatments are needed. The gene for the initiation of prostate cancer has not been identified; however, gene therapy can involve tumor injection of a gene to kill cells, systemic gene delivery to target and kill metastases, or local gene expression intended to generate a systemic response. This review will provide an overview of the various strategies of cancer gene therapy, focusing on those that have gone to clinical trial, detailing clinical experience in prostate cancer patients.
Stanizzi
Matthew A
MA
Department of Urology, The Barbara and Maurice A. Deane Prostate Health and Research Center, Mount Sinai School of Medicine New York, NY.
Hall
Simon J
SJ